These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 12803776
1. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats. Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E. J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776 [Abstract] [Full Text] [Related]
2. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat. De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR. Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388 [Abstract] [Full Text] [Related]
3. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents. Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ. Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316 [Abstract] [Full Text] [Related]
4. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P. Eur J Pharmacol; 2004 Mar 08; 487(1-3):125-32. PubMed ID: 15033384 [Abstract] [Full Text] [Related]
5. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors. Tordera RM, Monge A, Del Río J, Lasheras B. Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683 [Abstract] [Full Text] [Related]
6. Characterization of 4-(2-hydroxyphenyl)-1-[2'-[N-(2''-pyridinyl)-p-fluorobenzamido]ethyl]piperazine (p-DMPPF) as a new potent 5-HT1A antagonist. Defraiteur C, Plenevaux A, Scuvée-Moreau J, Rouchet N, Goblet D, Luxen A, Seutin V. Br J Pharmacol; 2007 Nov 03; 152(6):952-8. PubMed ID: 17704821 [Abstract] [Full Text] [Related]
7. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635. Collinson N, Dawson GR. Psychopharmacology (Berl); 1997 Jul 03; 132(1):35-43. PubMed ID: 9272757 [Abstract] [Full Text] [Related]
8. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA. Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724 [Abstract] [Full Text] [Related]
9. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation. Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E, Pawłowski M, Martinez J. Bioorg Med Chem; 2007 Apr 15; 15(8):2907-19. PubMed ID: 17321139 [Abstract] [Full Text] [Related]
10. Anxiolytic-like effect of lavender essential oil inhalation in mice: participation of serotonergic but not GABAA/benzodiazepine neurotransmission. Chioca LR, Ferro MM, Baretta IP, Oliveira SM, Silva CR, Ferreira J, Losso EM, Andreatini R. J Ethnopharmacol; 2013 May 20; 147(2):412-8. PubMed ID: 23524167 [Abstract] [Full Text] [Related]
11. Anxiolytic effects of prelimbic 5-HT(1A) receptor activation in the hemiparkinsonian rat. Hui YP, Wang T, Han LN, Li LB, Sun YN, Liu J, Qiao HF, Zhang QJ. Behav Brain Res; 2015 Jan 15; 277():211-20. PubMed ID: 24906197 [Abstract] [Full Text] [Related]
12. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system. Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M. Eur J Pharmacol; 2008 Jul 28; 589(1-3):117-21. PubMed ID: 18565508 [Abstract] [Full Text] [Related]
13. Involvement of presynaptic 5-HT(1A) and benzodiazepine receptors in the anticonflict activity of 5-HT(1A) receptor antagonists. Wesołowska A, Paluchowska M, Chojnacka-Wójcik E. Eur J Pharmacol; 2003 Jun 13; 471(1):27-34. PubMed ID: 12809949 [Abstract] [Full Text] [Related]
14. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635. Forster EA, Cliffe IA, Bill DJ, Dover GM, Jones D, Reilly Y, Fletcher A. Eur J Pharmacol; 1995 Jul 25; 281(1):81-8. PubMed ID: 8566121 [Abstract] [Full Text] [Related]
15. Gestational manganese intoxication and anxiolytic-like effects of diazepam and the 5-HT1A receptor agonist 8-OH-DPAT in male Wistar rats. Kwieciński A, Nowak P. Pharmacol Rep; 2009 Jul 25; 61(6):1061-8. PubMed ID: 20081241 [Abstract] [Full Text] [Related]
16. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist. Chojnacka-Wójcik E, Kłodzińska A, Tatarczyńska E, Paluchowska MH. Pol J Pharmacol; 1999 Jul 25; 51(5):405-13. PubMed ID: 10817541 [Abstract] [Full Text] [Related]
17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS, Assié MB, Koek W. J Pharmacol Exp Ther; 1997 Aug 25; 282(2):747-59. PubMed ID: 9262338 [Abstract] [Full Text] [Related]
18. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D. J Med Chem; 2004 May 06; 47(10):2659-66. PubMed ID: 15115407 [Abstract] [Full Text] [Related]
19. The hypotensive effect of BMY 7378 is antagonized by a silent 5-HT(1A) receptor antagonist: comparison with 8-hydroxy-dipropylamino tetralin. Villalobos-Molina R, López-Guerrero JJ, Ibarra M. Arch Med Res; 2001 May 06; 32(5):389-93. PubMed ID: 11578753 [Abstract] [Full Text] [Related]
20. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist. Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I. J Pharmacol Exp Ther; 2002 Sep 06; 302(3):1220-7. PubMed ID: 12183683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]